MS 1-2

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 535133

CAS#: 92758-98-0

Description: MS 1-2 is a bioactive chemical.

Chemical Structure

MS 1-2
CAS# 92758-98-0

Theoretical Analysis

MedKoo Cat#: 535133
Name: MS 1-2
CAS#: 92758-98-0
Chemical Formula: C22H29Cl2N3O4
Exact Mass: 469.1535
Molecular Weight: 470.391
Elemental Analysis: C, 56.17; H, 6.21; Cl, 15.07; N, 8.93; O, 13.60

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: MS 1-2; MS-1-2; MS1-2

IUPAC/Chemical Name: 1,4-Benzodioxan-2-carboxamide, N-((4-(2-phenoxyethyl)-1-piperazinyl)methyl)-, dihydrochloride


InChi Code: InChI=1S/C22H27N3O4.2ClH/c26-22(21-16-28-19-8-4-5-9-20(19)29-21)23-17-25-12-10-24(11-13-25)14-15-27-18-6-2-1-3-7-18;;/h1-9,21H,10-17H2,(H,23,26);2*1H


Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 470.391 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Sotnikov AV, Jood P, Ohta M. Enhancing the Thermoelectric Properties of Misfit Layered Sulfides (MS)1.2+q (NbS2) n (M = Gd and Dy) through Structural Evolution and Compositional Tuning. ACS Omega. 2020 May 26;5(22):13006-13013. doi: 10.1021/acsomega.0c00908. PMID: 32548485; PMCID: PMC7288565.

2: Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A. Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study. Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30. PMID: 27903815; PMCID: PMC5200855.

3: Cassotta A, Mikol V, Bertrand T, Pouzieux S, Le Parc J, Ferrari P, Dumas J, Auer M, Deisenhammer F, Gastaldi M, Franciotta D, Silacci-Fregni C, Fernandez Rodriguez B, Giacchetto-Sasselli I, Foglierini M, Jarrossay D, Geiger R, Sallusto F, Lanzavecchia A, Piccoli L. A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients. Nat Med. 2019 Sep;25(9):1402-1407. doi: 10.1038/s41591-019-0568-2. Epub 2019 Sep 9. PMID: 31501610; PMCID: PMC6795539.

4: Hsu SM, Hsu PL, Zhao X, Kao-Shan CS, Whang-Peng J. Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential. Cancer Res. 1988 Sep 15;48(18):5228-36. PMID: 2457437.

5: Sigurðsson HB, Sveinsson Þ, Briem K. Timing, not magnitude, of force may explain sex-dependent risk of ACL injury. Knee Surg Sports Traumatol Arthrosc. 2018 Aug;26(8):2424-2429. doi: 10.1007/s00167-018-4859-9. Epub 2018 Feb 10. PMID: 29429044; PMCID: PMC6061759.

6: Cladribine for multiple sclerosis. Drug Ther Bull. 2018 Feb;56(2):21-24. doi: 10.1136/dtb.2018.2.0590. PMID: 29449328.

7: Dicken L, Knock C, Carr DJ, Beckett S. The effect of fabric mass per unit area and blood impact velocity on bloodstain morphology. Forensic Sci Int. 2019 Aug;301:12-27. doi: 10.1016/j.forsciint.2019.05.001. Epub 2019 May 9. PMID: 31128405.

8: Lentferink YE, Kromwijk LAJ, van der Aa MP, Knibbe CAJ, van der Vorst MMJ. Increased Arterial Stiffness in Adolescents With Obesity. Glob Pediatr Health. 2019 Feb 25;6:2333794X19831297. doi: 10.1177/2333794X19831297. PMID: 30828593; PMCID: PMC6390226.

9: Lee TL, Reinhardt CD, Bartle SJ, Schwandt EF, Calvo-Lorenzo MS, Vahl C, Hagenmaier JA, Ritter MJ, Vogel GJ, Thomson DU. An epidemiological investigation to determine the prevalence and clinical manifestations of slow-moving finished cattle presented to slaughter facilities. Transl Anim Sci. 2018 Jun 9;2(3):241-253. doi: 10.1093/tas/txy056. PMID: 32704708; PMCID: PMC7200404.

10: Herraiz T, Papavergou E. Identification and occurrence of tryptamine- and tryptophan-derived tetrahydro-beta-carbolines in commercial sausages. J Agric Food Chem. 2004 May 5;52(9):2652-8. doi: 10.1021/jf0354601. PMID: 15113173.

11: Tanaka K, Kujuro Y, Suzuki S, Tanahashi N, Hamada J, Nogawa S, Suzuki N. Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002. Intern Med. 2005 Jun;44(6):560-6. doi: 10.2169/internalmedicine.44.560. PMID: 16020880.

12: Haneder S, Koziel K, Morelli JN, Riffel P, Budjan J, Schoenberg SO, Michaely HJ. Clinical application of 3D VIBECAIPI-DIXON for non-enhanced imaging of the pancreas compared to a standard 2D fat-saturated FLASH. Clin Imaging. 2014 Mar- Apr;38(2):142-7. doi: 10.1016/j.clinimag.2013.11.005. Epub 2013 Nov 19. PMID: 24332974.

13: Ornek E, Duran M, Ornek D, Demirçelik BM, Murat S, Kurtul A, Çiçekçioğlu H, Çetin M, Kahveci K, Doger C, Çetin Z. The effect of thrombolytic therapy on QT dispersion in acute myocardial infarction and its role in the prediction of reperfusion arrhythmias. Niger J Clin Pract. 2014 Mar-Apr;17(2):183-7. doi: 10.4103/1119-3077.127545. PMID: 24553029.

14: Ding-Zhou L, Margaill I, Palmier B, Pruneau D, Plotkine M, Marchand- Verrecchia C. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. Br J Pharmacol. 2003 Aug;139(8):1539-47. doi: 10.1038/sj.bjp.0705385. PMID: 12922942; PMCID: PMC1573979.

15: Dahl M. Genetic and biochemical markers of obstructive lung disease in the general population. Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x. PMID: 20298391.

16: Sánchez-Lázaro IJ, Sánchez-Gómez JM, Almenar-Bonet L, Martínez-Dolz L, Muño- Giner B, Portolés-Sanz M, Roselló-Lleti E, Cortés-Vergaz R, Rivera-Otero M, Salvador-Sanz A. Long-term prognostic implications of metabolic syndrome in heart transplant recipients. Transplant Proc. 2011 Jul-Aug;43(6):2257-9. doi: 10.1016/j.transproceed.2011.05.015. PMID: 21839250.

17: Itoh K, Tezuka H, Sakoda H, Konno M, Nagata K, Uchiyama T, Uchino H, Mori KJ. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol. 1989 Feb;17(2):145-53. PMID: 2783573.

18: Arroyo C, Cebrián G, Pagán R, Condón S. Inactivation of Cronobacter sakazakii by ultrasonic waves under pressure in buffer and foods. Int J Food Microbiol. 2011 Jan 5;144(3):446-54. doi: 10.1016/j.ijfoodmicro.2010.10.033. Epub 2010 Nov 4. PMID: 21111503.

19: Vincenti G, Monney P, Chaptinel J, Rutz T, Coppo S, Zenge MO, Schmidt M, Nadar MS, Piccini D, Chèvre P, Stuber M, Schwitter J. Compressed sensing single- breath-hold CMR for fast quantification of LV function, volumes, and mass. JACC Cardiovasc Imaging. 2014 Sep;7(9):882-92. doi: 10.1016/j.jcmg.2014.04.016. Epub 2014 Aug 13. PMID: 25129517.

20: Büyükafşar K, Un I. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur J Pharmacol. 2003 Jul 11;472(3):235-8. doi: 10.1016/s0014-2999(03)01905-8. PMID: 12871759.